• Patient-Derived Gastric Cancer Assembloids Reveal Stromal Im

  2026-07-09

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with autologous stromal cell subpopulations. By more accurately replicating tumor microenvironment complexity, the model enables nuanced investigation of drug responses and resistance mechanisms, supporting the advancement of preclinical and personalized cancer research.

• Berberine Modulates SASP Inflammation via RXRα/PPARγ/NEDD4 i

  2026-07-08

  This study delineates how berberine suppresses senescence-associated secretory phenotype (SASP)-driven inflammation in atherosclerosis by activating the RXRα/PPARγ/NEDD4 pathway in macrophage-derived foam cells. The findings clarify the mechanistic role of RXRα/PPARγ signaling in vascular aging and suggest new strategies for targeting chronic inflammation in cardiovascular disease.

• Lymphatic Vessels in Sepsis-Induced Cardiomyopathy: Mechanis

  2026-07-08

  This study reveals that functional lymphatic vessels are essential for preserving cardiac function and resolving inflammation during sepsis-induced cardiomyopathy (SICM). By elucidating the protective role of VEGFC-mediated lymphangiogenesis and its interplay with the MAPK signaling pathway, the findings offer a mechanistic framework for novel SICM interventions and highlight experimental strategies for protein extraction and analysis.

• Kanamycin Sulfate and Circular RNA: Next-Gen Selection Tools

  2026-07-07

  This thought-leadership article explores how APExBIO’s Kanamycin Sulfate supports advanced translational research, bridging antibiotic selection with emerging RNA therapeutic workflows. We contextualize mechanistic insights into kanamycin action, examine recent breakthroughs in circular RNA purification, and deliver strategic guidance for researchers seeking to elevate microbiology and molecular biology studies beyond standard protocols. Evidence-based recommendations, practical protocol parameters, and an analysis of the evolving research landscape are provided.

• Hydroxychloroquine Sulfate for Autoimmune Disease Research W

  2026-07-07

  Hydroxychloroquine Sulfate (SKU B4874) is a synthetic quinoline derivative widely used to inhibit autophagy and TLR7/9 signaling in autoimmune disease research, especially for systemic lupus erythematosus and rheumatoid arthritis models. It is best suited for aqueous-based, short-term protocols and should not be used in workflows requiring organic solvent solubility or long-term solution storage.

• Berberine Suppresses SASP Inflammation via RXRα/PPARγ/NEDD4

  2026-07-06

  This study elucidates how berberine inhibits senescence-associated inflammation in atherosclerosis by modulating the RXRα/PPARγ/NEDD4 signaling pathway. These findings clarify the mechanistic link between metabolic nuclear receptors and inflammatory aging, providing new strategies for targeting chronic vascular inflammation.

• Advancing In Vitro Drug Response Evaluation in Cancer Resear

  2026-07-06

  Schwartz's dissertation introduces a rigorous framework for distinguishing drug-induced proliferative arrest from cell death in cancer models, challenging the common practice of using relative viability as a sole endpoint. These insights reshape how anti-proliferative agents and apoptosis inducers, such as JNJ-26854165 (Serdemetan), are evaluated and benchmarked in preclinical studies.

• BRD4 Inhibition Enhances Erastin-Induced Ferroptosis via ROS

  2026-07-05

  This study demonstrates that BRD4 inhibitors, including I-BET-762, broadly sensitize diverse cancer cell lines to erastin-induced ferroptosis by promoting reactive oxygen species (ROS) accumulation and downregulating FSP1. These findings clarify the mechanistic interplay between BET inhibition and ferroptosis, suggesting new strategies for leveraging epigenetic modulation in cancer biology and disease modeling.

• Micellar Spectrofluorimetry of Alfuzosin HCl and Vardenafil:

  2026-07-04

  This study introduces a sensitive, eco-friendly micellar spectrofluorimetric method for the simultaneous quantification of Alfuzosin HCl and vardenafil in pharmaceuticals and biological fluids. The work advances analytical protocols in benign prostatic hyperplasia (BPH) research, enabling precise monitoring of α1 adrenoceptor antagonist co-administration.

• Recombinant Mouse SHH: Precision Tools for Developmental Pat

  2026-07-03

  Explore how Recombinant Mouse Sonic Hedgehog (SHH) protein empowers developmental biology and congenital malformation research. This article uniquely integrates mechanistic insights, comparative embryology, and practical assay guidance for advanced patterning studies.

• (S)-(+)-Dimethindene maleate: Parameters for M2 Antagonism S

  2026-07-03

  (S)-(+)-Dimethindene maleate is a selective M2 muscarinic receptor antagonist and H1 histamine receptor blocker, designed to provide rigorous pharmacological control in autonomic regulation, cardiovascular, and respiratory function research. It is not suitable for diagnostic or therapeutic use, nor for extended solution storage. This guide details actionable handling and experimental setup to optimize reproducibility in receptor pathway studies.

• Plant Exosome-like Nanovesicles Rescue Sertoli Cell Function

  2026-07-02

  The referenced study demonstrates that plant-derived exosome-like nanovesicles from Cistanche deserticola (CDELNs) mitigate cyclophosphamide-induced testicular injury by targeting cell cycle arrest in Sertoli cells. This discovery highlights a novel, natural intervention strategy for male reproductive toxicity resulting from chemotherapy.

• Meropenem: Optimized Workflows for β-Lactam Antibiotic Carba

  2026-07-02

  Meropenem’s ultra-broad spectrum and robust β-lactam mechanism position it as a gold-standard tool for modeling Gram-negative and Gram-positive infections in translational research. This guide delivers actionable workflow enhancements, data-backed troubleshooting, and comparative insights for researchers confronting the frontiers of antimicrobial resistance.

• Berberine Targets RXRα/PPARγ/NEDD4 to Suppress Atherosclerot

  2026-07-01

  A recent study reveals that berberine suppresses senescence-associated inflammation in atherosclerosis by activating the RXRα/PPARγ/NEDD4 pathway, leading to targeted degradation of pro-inflammatory complexes in macrophage-derived foam cells. These findings clarify the molecular basis for berberine's anti-aging effects in vascular disease and open new avenues for mechanistic research on PPARγ signaling.

• Docetaxel in Quantitative Drug Response: From Microtubules t

  2026-07-01

  Explore how Docetaxel (Taxotere) serves as a benchmark for quantitative cancer drug response, with a focus on cell cycle arrest, apoptosis, and assay optimization. This article offers a unique, data-driven approach that advances practical decisions in chemotherapy research.

407 records 9/28 page Previous Next First page 上5页 678910 下5页 Last page